Technical Analysis for ANEB - Anebulo Pharmaceuticals, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 1.84 | -2.13% | -0.04 |
ANEB closed down 2.13 percent on Friday, November 1, 2024, on 7 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Nov 12
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Bollinger Band Squeeze | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Stochastic Reached Oversold | Weakness | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Gapped Down | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| 20 DMA Resistance | Bearish | -2.13% | |
| Bollinger Band Squeeze | Range Contraction | -2.13% | |
| Outside Day | Range Expansion | -2.13% | |
| Oversold Stochastic | Weakness | -2.13% |
| Alert | Time |
|---|---|
| Possible Inside Day | about 20 hours ago |
| Down 2 % | about 23 hours ago |
| Down 1% | about 23 hours ago |
| Fell Below 10 DMA | about 23 hours ago |
| Outside Day | 2 days ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/12/2024
Anebulo is a clinical-stage biotechnology company developing novel solutions for people suffering from cannabinoid overdose and substance addiction. Its lead product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within one hour of administration. Clinical trials completed to date have shown that ANEB-001 is rapidly absorbed, well tolerated and leads to weight loss, an effect that is consistent with central cannabinoid receptor type 1 antagonism.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cannabis Smoking Cannabinoid Addiction Abnormal Psychology
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cannabis Smoking Cannabinoid Addiction Abnormal Psychology
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 3.3 |
| 52 Week Low | 1.72 |
| Average Volume | 8,915 |
| 200-Day Moving Average | 2.35 |
| 50-Day Moving Average | 1.95 |
| 20-Day Moving Average | 1.88 |
| 10-Day Moving Average | 1.86 |
| Average True Range | 0.11 |
| RSI (14) | 46.24 |
| ADX | 14.97 |
| +DI | 28.10 |
| -DI | 19.32 |
| Chandelier Exit (Long, 3 ATRs) | 1.69 |
| Chandelier Exit (Short, 3 ATRs) | 2.15 |
| Upper Bollinger Bands | 1.95 |
| Lower Bollinger Band | 1.80 |
| Percent B (%b) | 0.26 |
| BandWidth | 8.04 |
| MACD Line | -0.03 |
| MACD Signal Line | -0.04 |
| MACD Histogram | 0.0033 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.84 | ||||
| Resistance 3 (R3) | 1.84 | 1.84 | 1.84 | ||
| Resistance 2 (R2) | 1.84 | 1.84 | 1.84 | 1.84 | |
| Resistance 1 (R1) | 1.84 | 1.84 | 1.84 | 1.84 | 1.84 |
| Pivot Point | 1.84 | 1.84 | 1.84 | 1.84 | 1.84 |
| Support 1 (S1) | 1.84 | 1.84 | 1.84 | 1.84 | 1.84 |
| Support 2 (S2) | 1.84 | 1.84 | 1.84 | 1.84 | |
| Support 3 (S3) | 1.84 | 1.84 | 1.84 | ||
| Support 4 (S4) | 1.84 |
